Alembic Pharmaceuticals has received a formal warning letter from the U.S. Food and Drug Administration targeting its bioequivalence research facility in Vadodara, India. The warning letter, dated July 10, 2026, follows an
MoreSkadden Arps faces mounting political pressure over its conflict of interest concerns tied to its deal with the Trump administration and its simultaneous legal work for Intel. Senators Richard Blumenthal and Adam
MoreLegendary investor Warren Buffett has long been regarded as one of the most reliable voices in finance during periods of market turbulence and uncertainty. Buffett’s approach to stock market crashes centres on
MoreApple (AAPL) has filed a lawsuit against OpenAI and two of its former employees, accusing them of stealing confidential information about its unreleased technologies and products. The iPhone maker filed the suit
MoreThe FTSE 100 climbed 64 points to 10,715.5 on Tuesday, with consumer-facing stocks and energy names providing the bulk of upward momentum in early trading. Burberry led the risers with a gain
MoreA US federal court in California has granted summary judgment in favour of a pharmaceutical employer despite acknowledging the plaintiff had likely engaged in protected whistleblowing activity. The case, Han v. Pfizer
MoreThe London Stock Exchange has drawn up a worst-case scenario analysis warning that as many as 20 FTSE 100 companies could shift their direct listings to New York. The analysis, seen by
MoreDraftKings Inc. (DKNG) has been hit with a lawsuit in California alleging its website secretly collected data from visitors using software linked to multiple third-party data brokers. The case, filed in the
MoreMajor UK lenders including Barclays and Lloyds are developing a plan allowing customers to use digital identification tools directly within their banking apps. The initiative also involves HSBC, Nationwide, NatWest and Santander,
MoreThe US energy sector continues to attract investor attention in 2026, with several stocks demonstrating notable earnings growth while carrying meaningful funding risk exposure. Energy companies with strong earnings trajectories are not
More
